Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial - PubMed

Norwegian Research Council.
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov